Epidemiology and clinical outcomes of bloodstream infections among lupus patients

Lupus

Volumn 20, Issue 9, 2011, Pages 965-971

  Marcos, M ^a   Fernandez C ^a   Soriano, A ^a   Marco, F ^a   Martinez J A ^a   Almela, M ^a   Cervera, R ^a   Mensa, J ^a   Espinosa, G ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

bacteraemia epidemiology; bacteraemia microbiology; follow up studies; survival analysis; systemic lupus erythematosus

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; BETA LACTAMASE; C REACTIVE PROTEIN; CARBAPENEM; CEFTAZIDIME; CEPHALOSPORIN; CIPROFLOXACIN; CLINDAMYCIN; CORTICOSTEROID; GLYCOPEPTIDE; IMIPENEM; METRONIDAZOLE; QUINOLONE; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BACTEREMIA; BLOODSTREAM INFECTION; CAUSE OF DEATH; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE DURATION; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; LENGTH OF STAY; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; SYSTEMIC LUPUS ERYTHEMATOSUS; URINARY CATHETER;

ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; C-REACTIVE PROTEIN; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SPAIN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80052519157     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203311403345     Document Type: Article

References (26)

1. Noel V, Lortholary O, Casassus P, et al. Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematosus. Ann Rheum Dis. 2001 ; 60: 1141-1144 (Pubitemid 33096079)
2. Cervera R, Khamashta MA, Font J, et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1000 patients. Medicine (Baltimore). 2003 ; 82: 299-308 (Pubitemid 37229465)
3. Bosch X, Guilabert A, Pallares L, et al. Infections in systemic lupus erythematosus: a prospective and controlled study of 110 patients. Lupus. 2006 ; 15: 584-589 (Pubitemid 44661745)
4. Navarro-Zarza JE, Alvarez-Hernandez E, Casasola-Vargas JC, Estrada-Castro E, Burgos-Vargas R. Prevalence of community-acquired and nosocomial infections in hospitalized patients with systemic lupus erythematosus. Lupus. 2010 ; 19: 43-48
5. Iliopoulos AG, Tsokos GC. Immunopathogenesis and spectrum of infections in systemic lupus erythematosus. Semin Arthritis Rheum. 1996 ; 25: 318-336 (Pubitemid 26123844)
6. Gladman DD, Hussain F, Ibanez D, Urowitz MB. The nature and outcome of infection in systemic lupus erythematosus. Lupus. 2002 ; 11: 234-239 (Pubitemid 34506728)
7. Taylor GD, McKenzie M, Kirkland T, Buchanan-Chell M, Wiens R. The impact of health care restructuring on nosocomially acquired blood stream infections. Can J Infect Dis. 2000 ; 11: 34-37 (Pubitemid 30143818)
8. Minino AM, Heron MP, Murphy SL, Kochanek KD. Deaths: final data for 2004. Natl Vital Stat Rep. 2007 ; 55: 1-119
9. Ramphal R. Importance of adequate initial antimicrobial therapy. Chemotherapy. 2005 ; 51: 171-176 (Pubitemid 41404694)
10. Harbarth S, Nobre V, Pittet D. Does antibiotic selection impact patient outcome?. Clin Infect Dis. 2007 ; 44: 87-93 (Pubitemid 44968991)
11. Zhou WJ, Yang CD. The causes and clinical significance of fever in systemic lupus erythematosus: a retrospective study of 487 hospitalised patients. Lupus. 2009 ; 18: 807-812
12. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. NCCLS document M100-S12. Wayne, PA: NCCLS, 2000
13. Weinstein MP, Murphy JR, Reller LB, Lichtenstein KA. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. II. Clinical observations, with special reference to factors influencing prognosis. Rev Infect Dis. 1983 ; 5: 54-70
14. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988 ; 16: 128-140
15. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987 ; 40: 373-383 (Pubitemid 17055592)
16. Cervera R, Abarca-Costalago M, Abramovicz D, et al. Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the 'Euro-Lupus Project'. Autoimmun Rev. 2006 ; 5: 180-186 (Pubitemid 43234182)
17. Hellmann DB, Petri M, Whiting-O'Keefe Q. Fatal infections in systemic lupus erythematosus: the role of opportunistic organisms. Medicine (Baltimore). 1987 ; 66: 341-348 (Pubitemid 18020233)
18. Nived O, Sturfelt G, Wollheim F. Systemic lupus erythematosus and infection: a controlled and prospective study including an epidemiological group. Q J Med. 1985 ; 55: 271-287 (Pubitemid 15028242)
19. Duffy KN, Duffy CM, Gladman DD. Infection and disease activity in systemic lupus erythematosus: a review of hospitalized patients. J Rheumatol. 1991 ; 18: 1180-1184
20. Goldblatt F, Chambers S, Rahman A, Isenberg DA. Serious infections in British patients with systemic lupus erythematosus: hospitalisations and mortality. Lupus. 2009 ; 18: 682-689
21. Lee P, Urowitz MB, Bookman AA, et al. Systemic lupus erythematosus. A review of 110 cases with reference to nephritis, the nervous system, infections, aseptic necrosis and prognosis. Q J Med. 1977 ; 46: 1-32 (Pubitemid 8041047)
22. Abu-Shakra M, Urowitz MB, Gladman DD, Gough J. Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death. J Rheumatol. 1995 ; 22: 1259-1264
23. Chen MJ, Tseng HM, Huang YL, et al. Long-term outcome and short-term survival of patients with systemic lupus erythematosus after bacteraemia episodes: 6-yr follow-up. Rheumatology (Oxford). 2008 ; 47: 1352-1357
24. Marsik C, Kazemi-Shirazi L, Schickbauer T, et al. C-reactive protein and all-cause mortality in a large hospital-based cohort. Clin Chem. 2008 ; 54: 343-349 (Pubitemid 351302621)
25. Kompoti M, Drimis S, Papadaki A, et al. Serum C-reactive protein at admission predicts in-hospital mortality in medical patients. Eur J Intern Med. 2008 ; 19: 261-265
26. Hidalgo-Tenorio C, Jimenez-Alonso J, de Dios Luna J, Tallada M, Martinez-Brocal A, Sabio JM. Urinary tract infections and lupus erythematosus. Ann Rheum Dis. 2004 ; 63: 431-437 (Pubitemid 38453311)